Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-08-10

Clinical Trial Update: Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

View source ↗

Summary

The study evaluating Humira (adalimumab) for psoriatic arthritis, including safety, effectiveness, and effects on quality of life and work productivity in clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Psoriatic Arthritis | Status: WITHDRAWN